GLP-1 S

Product Overview Semaglutide is a synthetic GLP-1 receptor agonist analogue consisting of 31 amino acids with modifications for enhanced stability. It is supplied as a lyophilized powder for stability in laboratory settings.

Key Specifications

• CAS Number: 910463-68-2
• Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
• Molecular Weight: 4113.64 g/mol
• Sequence: His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(N6-[N-(17-carboxy-1-oxoheptadecyl)-L-γ-glutamyl[2-(2-aminoethoxy)ethoxy]acetyl[2-(2-aminoethoxy)ethoxy]acetyl])-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly
• Form: White lyophilized powder in sealed glass vial
• Quantity: 10mg per vial
• Purity: ≥99% (verified by third-party HPLC testing)
• Storage: Store lyophilized at -20°C; reconstituted solutions at 2-8°C. Protect from light and moisture.
• Solubility: Soluble in bacteriostatic water or sterile saline for research reconstitution.

Research Notes Semaglutide is a long-acting GLP-1 analogue commonly used in in vitro and preclinical studies exploring glucose homeostasis, receptor agonism, and metabolic pathways. Independent Certificates of Analysis (COAs) and lab reports are provided with each batch for verification of identity, purity, and endotoxin levels.

Important Disclaimer This product is intended strictly for research purposes only. It is not for human or veterinary consumption, diagnostic, or therapeutic use. Not evaluated by the FDA. Researchers must comply with all applicable laws and regulations.